Abstract:Objective: To measure the relative effects of each of four phytosterol ester-enriched low-fat foods (bread, breakfast cereal, milk and yoghurt) on serum lipids, plasma phytosterols and carotenoids. Design: Three research centres undertook a randomised, incomplete crossover, single-blind study consisting of four treatment periods of 3 weeks each, one of which was a control period. Each sterol-enriched test food provided 1.6 g/day of phytosterols as sterol esters. Setting: General Community. Subjects: In all 58,… Show more
“…Many of the recent studies that investigated the cholesterol-lowering effect of PS or stanols incorporated into low-fat foods and beverages have reported that the food products have been taken with a meal or as part of a meal. This has been the case for the following food products: cereal and bread (Nestel et al, 2001), lemonade (Spilburg et al, 2003), milk and yoghurt (Mensink et al, 2002;Clifton et al, 2004;Thomsen et al, 2004) and orange juice (Devaraj et al, 2004). Further, a greater effectiveness of consuming plant sterols daily with every meal versus the same dose every other day has been reported in an animal study (Hayes et al, 2002).…”
Section: Discussionmentioning
confidence: 98%
“…Recently, several studies have shown that consumption of PS-enriched low-fat or nonfat foods like bread, cereals, milk, yoghurt or orange juice significantly lowered TC and LDL-C, demonstrating their cholesterol-lowering efficacy (Nestel et al, 2001;Mensink et al, 2002;Spilburg et al, 2003;Clifton et al, 2004;Devaraj et al, 2004;Thomsen et al, 2004;Noakes et al, 2005). However, a few studies have suggested that the cholesterol-lowering effect of PS may be weakened when provided as low-fat or nonfat foods and beverages (Denke, 1995;Jones et al, 2003) implying that optimal efficacy is not always achieved with such food formats.…”
Objective: To determine the impact of intake occasion (with or without a meal), and product fat level on the cholesterollowering efficacy of a plant sterol (PS)-enriched (3 g/day) single-dose yoghurt drink. Design: Double-blind, randomized, placebo-controlled, parallel study with a 4 weeks run-in and 4 weeks intervention period. Setting: Subjects recruited from the general community. Subjects: A total of 184 moderate hypercholesterolaemic subjects (81 men and 103 women) (age 5772 years) completed the study. Interventions: The study product was a 100-g single-dose yoghurt drink with or without added PS in the form of PS esters. The subjects were randomly assigned to one of five 4-week treatments: (i) drink A (0.1% dairy fat, 2.2% total fat) with a meal, (ii) drink A without a meal, (iii) drink B (1.5% dairy fat, 3.3% total fat) with a meal, (iv) drink B without a meal and (v) placebo drink with a meal. Results: LDL-cholesterol (LDL-C) was significantly lowered when the single-dose drink was taken with a meal independent of its fat content (drink A: À9.5% (Po0.001, 95% CI: À13.8 to À5.2); drink B: À9.3% (Po0.001, 95% CI: À13.7 to À4.9)) as compared to placebo. When consumed without a meal, LDL-C was also significantly decreased (drink A: À5.1% (Po0.05, 95% CI: À9.4 to À0.8); drink B: À6.9% (Po0.01, 95% CI: À11.3 to À2.5) as compared to placebo, however the effect was significantly smaller as compared to the intake with a meal. Conclusion: These results indicate that a PS-ester-enriched single-dose yoghurt drink effectively reduces LDL-C irrespective of the fat content of the product. A substantially larger decrease in serum cholesterol concentration was achieved when the singledose drink was consumed with a meal emphasizing the importance of the intake occasion for optimal cholesterol-lowering efficacy.
“…Many of the recent studies that investigated the cholesterol-lowering effect of PS or stanols incorporated into low-fat foods and beverages have reported that the food products have been taken with a meal or as part of a meal. This has been the case for the following food products: cereal and bread (Nestel et al, 2001), lemonade (Spilburg et al, 2003), milk and yoghurt (Mensink et al, 2002;Clifton et al, 2004;Thomsen et al, 2004) and orange juice (Devaraj et al, 2004). Further, a greater effectiveness of consuming plant sterols daily with every meal versus the same dose every other day has been reported in an animal study (Hayes et al, 2002).…”
Section: Discussionmentioning
confidence: 98%
“…Recently, several studies have shown that consumption of PS-enriched low-fat or nonfat foods like bread, cereals, milk, yoghurt or orange juice significantly lowered TC and LDL-C, demonstrating their cholesterol-lowering efficacy (Nestel et al, 2001;Mensink et al, 2002;Spilburg et al, 2003;Clifton et al, 2004;Devaraj et al, 2004;Thomsen et al, 2004;Noakes et al, 2005). However, a few studies have suggested that the cholesterol-lowering effect of PS may be weakened when provided as low-fat or nonfat foods and beverages (Denke, 1995;Jones et al, 2003) implying that optimal efficacy is not always achieved with such food formats.…”
Objective: To determine the impact of intake occasion (with or without a meal), and product fat level on the cholesterollowering efficacy of a plant sterol (PS)-enriched (3 g/day) single-dose yoghurt drink. Design: Double-blind, randomized, placebo-controlled, parallel study with a 4 weeks run-in and 4 weeks intervention period. Setting: Subjects recruited from the general community. Subjects: A total of 184 moderate hypercholesterolaemic subjects (81 men and 103 women) (age 5772 years) completed the study. Interventions: The study product was a 100-g single-dose yoghurt drink with or without added PS in the form of PS esters. The subjects were randomly assigned to one of five 4-week treatments: (i) drink A (0.1% dairy fat, 2.2% total fat) with a meal, (ii) drink A without a meal, (iii) drink B (1.5% dairy fat, 3.3% total fat) with a meal, (iv) drink B without a meal and (v) placebo drink with a meal. Results: LDL-cholesterol (LDL-C) was significantly lowered when the single-dose drink was taken with a meal independent of its fat content (drink A: À9.5% (Po0.001, 95% CI: À13.8 to À5.2); drink B: À9.3% (Po0.001, 95% CI: À13.7 to À4.9)) as compared to placebo. When consumed without a meal, LDL-C was also significantly decreased (drink A: À5.1% (Po0.05, 95% CI: À9.4 to À0.8); drink B: À6.9% (Po0.01, 95% CI: À11.3 to À2.5) as compared to placebo, however the effect was significantly smaller as compared to the intake with a meal. Conclusion: These results indicate that a PS-ester-enriched single-dose yoghurt drink effectively reduces LDL-C irrespective of the fat content of the product. A substantially larger decrease in serum cholesterol concentration was achieved when the singledose drink was consumed with a meal emphasizing the importance of the intake occasion for optimal cholesterol-lowering efficacy.
“…When oxidized with cholesterol oxidase and derivatized with GP hydrazine, CID of the resulting C 4,24 -3-one GP hydrazone (II) gives a The level of the plant sterol sitosterol in serum is often used as a marker for cholesterol absorption. Sterol esters, including those of sitosterol and stigmasterol, are present in phytosterol ester enriched low-fat food products, and their consumption has been shown to reduce serum total and LDL cholesterol levels [55,56]. Conversely, phytosterol levels in plasma become elevated upon consumption of these foods [55].…”
Section: Cholesterol Cholestadienes and Side-chain Modified Cholestmentioning
confidence: 99%
“…Sterol esters, including those of sitosterol and stigmasterol, are present in phytosterol ester enriched low-fat food products, and their consumption has been shown to reduce serum total and LDL cholesterol levels [55,56]. Conversely, phytosterol levels in plasma become elevated upon consumption of these foods [55]. The CID spectra of C 4 -24-ethyl-3-one (III) and C 4,22 -24-ethyl-3-one (IV) GP hydrazones showed the common features of 3-oxo-⌬ 4 GP hydrazones (Figure 3d and Supplementary Material Figure S-4).…”
Section: Cholesterol Cholestadienes and Side-chain Modified Cholestmentioning
Oxysterols are oxygenated derivatives of cholesterol. They are intermediates in cholesterol excretion pathways and may also be regarded as transport forms of cholesterol. The introduction of additional hydroxyl groups to the cholesterol skeleton facilitates the flux of oxysterols across the blood brain barrier, and oxysterols have been implicated in mediating a number of cholesterol-induced metabolic effects. Oxysterols are difficult to analyze by atmospheric pressure ionization mass spectrometry on account of the absence of basic or acidic functional groups in their structures. In this communication, we report a method for the derivatization and analysis of oxysterols by electrospray mass spectrometry. Oxysterols with a 3-hydroxy-⌬ 5 structure were converted by cholesterol oxidase to 3-oxo-⌬ 4 steroids and then derivatized with the Girard P reagent to give Girard P hydrazones, which were subsequently analyzed by tandem mass spectrometry. The improvement in sensitivity for the analysis of 25-hydroxycholesterol upon oxidation and derivatization was over 1000. (J Am Soc Mass Spectrom 2006, 17, 341-362)
“…Numerous laboratory studies focused on their potential to reduce cholesterol absorption by the small intestine, [1][2][3][4] and cholesterol uptake by LDL. [5][6][7] In addition, it was reported that phytosterols prevent coronary heart disease, 8 and cardiovascular risks. [9][10][11] However, their potential to reduce the risk of cancer remains controversial.…”
Plant sterols are found in fruits and vegetables. Their cholesterol-lowering effect is well documented. Our study aimed at comparing antiproliferative effects of 7b-hydroxysitosterol (7b-OHsito) versus 7b-hydroxycholesterol (7b-OHchol) on the human colon cancer cell line Caco-2. When cells were exposed for 32 h to 60 lM 7b-OHsito or to 30 lM 7b-OHchol, both compounds caused 50% growth inhibition. Cells treated with 7b-OHsito showed enhanced caspase-9 and -3 activities followed by DNA fragmentation. In contrast, 7b-OHchol did not activate caspase-3 and activation of caspase-9 and DNA fragmentation were delayed. The treatment of cells with the caspase inhibitor Z-VAD.fmk retarded the 7b-OHsito-induced apoptotic process but not that triggered by 7b-OHchol. Our data suggest that the two compounds in spite of their structural similarities target different cellular pathways, which lead to cell death.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.